Donald E.  Bobo, Jr net worth and biography

Donald Bobo, Jr Biography and Net Worth

Donald E. Bobo, Jr., has been corporate vice president since 2007 and is currently responsible for the company’s corporate strategy and corporate development functions. In addition, Bobo has executive responsibility for disease awareness and heart failure initiatives as well as the healthcare solutions and commercial services team. Bobo has more than 30 years of experience in the medical products and healthcare industry in various leadership roles at Edwards including, most recently, the development of the company’s Transcatheter Mitral and Tricuspid Therapies organization, vice president and general manager of the Surgical Structural Heart business and global valve manufacturing operations. Prior to joining Edwards, Bobo held a variety of roles with increasing levels of responsibilities with American Hospital Supply and Baxter Healthcare, including research and development, business development, operations and general management. He has served as board chairman of the California Life Sciences Association (CLSA). Bobo received a bachelor's degree in mathematics from Bob Jones University, and a master's degree in engineering from the University of Southern California.

What is Donald E. Bobo, Jr's net worth?

The estimated net worth of Donald E. Bobo, Jr is at least $4.16 million as of June 12th, 2024. Mr. Bobo, Jr owns 46,936 shares of Edwards Lifesciences stock worth more than $4,155,244 as of June 19th. This net worth evaluation does not reflect any other assets that Mr. Bobo, Jr may own. Learn More about Donald E. Bobo, Jr's net worth.

How do I contact Donald E. Bobo, Jr?

The corporate mailing address for Mr. Bobo, Jr and other Edwards Lifesciences executives is ONE EDWARDS WAY, IRVINE CA, 92614. Edwards Lifesciences can also be reached via phone at (949) 250-2500 and via email at [email protected]. Learn More on Donald E. Bobo, Jr's contact information.

Has Donald E. Bobo, Jr been buying or selling shares of Edwards Lifesciences?

During the past quarter, Donald E. Bobo, Jr has sold $876,750.00 in shares of Edwards Lifesciences stock. Most recently, Donald E. Bobo, Jr. sold 5,000 shares of the business's stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $87.54, for a transaction totalling $437,700.00. Following the completion of the sale, the vice president now directly owns 46,936 shares of the company's stock, valued at $4,108,777.44. Learn More on Donald E. Bobo, Jr's trading history.

Who are Edwards Lifesciences' active insiders?

Edwards Lifesciences' insider roster includes Donald Bobo, Jr (VP), Daveen Chopra (VP), Kieran Gallahue (Director), Leslie Heisz (Director), Jean-Luc Lemercier (VP), Daniel Lippis (VP), Martha Marsh (Director), Michael Mussallem (CEO), Robert Sellers (VP), Catherine Szyman (VP), Scott Ullem (CFO), Nicholas Valeriani (Director), Huimin Wang (VP), Larry Wood (VP), and Bernard Zovighian (VP). Learn More on Edwards Lifesciences' active insiders.

Are insiders buying or selling shares of Edwards Lifesciences?

In the last year, Edwards Lifesciences insiders bought shares 1 times. They purchased a total of 580 shares worth more than $49,729.20. In the last year, insiders at the medical research company sold shares 59 times. They sold a total of 669,860 shares worth more than $54,017,269.18. The most recent insider tranaction occured on June, 12th when VP Donald E Bobo Jr sold 5,000 shares worth more than $437,700.00. Insiders at Edwards Lifesciences own 1.3% of the company. Learn More about insider trades at Edwards Lifesciences.

Information on this page was last updated on 6/12/2024.

Donald E. Bobo, Jr Insider Trading History at Edwards Lifesciences

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/12/2024Sell5,000$87.54$437,700.0046,936View SEC Filing Icon  
5/10/2024Sell5,000$87.81$439,050.0047,750View SEC Filing Icon  
3/13/2024Sell14,500$91.01$1,319,645.0039,503View SEC Filing Icon  
2/13/2024Sell11,000$85.83$944,130.0039,503View SEC Filing Icon  
1/12/2024Sell10,000$75.67$756,700.0039,503View SEC Filing Icon  
12/13/2023Sell8,000$71.86$574,880.0039,503View SEC Filing Icon  
11/13/2023Sell6,000$65.30$391,800.0039,503View SEC Filing Icon  
10/13/2023Sell5,000$69.98$349,900.0039,503View SEC Filing Icon  
9/14/2023Sell4,500$73.71$331,695.0039,503View SEC Filing Icon  
8/14/2023Sell4,500$79.30$356,850.0039,503View SEC Filing Icon  
7/14/2023Sell3,500$92.94$325,290.0039,503View SEC Filing Icon  
5/5/2023Sell5,635$88.62$499,373.7056,225View SEC Filing Icon  
4/6/2023Sell6,725$83.09$558,780.2562,824View SEC Filing Icon  
2/6/2023Sell6,725$80.75$543,043.7562,561View SEC Filing Icon  
1/9/2023Sell6,725$77.50$521,187.5062,561View SEC Filing Icon  
12/12/2022Sell6,725$74.32$499,802.0062,561View SEC Filing Icon  
11/8/2022Sell6,725$68.46$460,393.5062,561View SEC Filing Icon  
10/10/2022Sell6,725$85.00$571,625.0062,561View SEC Filing Icon  
10/10/2022Sell6,725$85.00$571,625.0062,561View SEC Filing Icon  
9/8/2022Sell6,725$90.94$611,571.5062,561View SEC Filing Icon  
7/8/2022Sell6,725$97.60$656,360.0062,561View SEC Filing Icon  
6/13/2022Sell6,725$90.02$605,384.5062,561View SEC Filing Icon  
4/8/2022Sell11,050$123.34$1,362,907.00152,326View SEC Filing Icon  
3/11/2022Sell11,050$106.00$1,171,300.00View SEC Filing Icon  
2/11/2022Sell11,050$111.49$1,231,964.50View SEC Filing Icon  
1/28/2022Sell11,050$101.15$1,117,707.50View SEC Filing Icon  
11/5/2021Sell11,050$117.17$1,294,728.50View SEC Filing Icon  
10/8/2021Sell11,050$110.49$1,220,914.50View SEC Filing Icon  
9/10/2021Sell11,050$122.25$1,350,862.50View SEC Filing Icon  
8/6/2021Sell11,050$114.37$1,263,788.5067,449View SEC Filing Icon  
5/7/2021Sell11,050$92.52$1,022,346.0063,895View SEC Filing Icon  
3/12/2021Sell13,077$82.85$1,083,429.4561,585View SEC Filing Icon  
2/5/2021Sell13,077$85.80$1,122,006.6061,585View SEC Filing Icon  
1/8/2021Sell13,077$90.45$1,182,814.6561,585View SEC Filing Icon  
12/11/2020Sell13,074$84.65$1,106,714.1061,582View SEC Filing Icon  
11/13/2020Sell13,074$80.56$1,053,241.4461,582View SEC Filing Icon  
11/9/2020Sell227$83.89$19,043.0348,508View SEC Filing Icon  
11/6/2020Sell347$78.01$27,069.4748,508View SEC Filing Icon  
9/11/2020Sell13,074$82.45$1,077,951.3061,582View SEC Filing Icon  
8/6/2020Sell12,000$77.28$927,360.0072,832View SEC Filing Icon  
7/10/2020Sell13,074$67.46$881,972.0485,906View SEC Filing Icon  
5/15/2020Sell4,358$215.16$937,667.2828,609View SEC Filing Icon  
5/8/2020Sell5,372$220.94$1,186,889.6822,447View SEC Filing Icon  
4/3/2020Sell5,369$182.44$979,520.3626,191View SEC Filing Icon  
2/7/2020Sell5,369$235.65$1,265,204.8526,082View SEC Filing Icon  
1/10/2020Sell5,369$235.69$1,265,419.6126,082View SEC Filing Icon  
12/11/2019Sell5,369$229.26$1,230,896.9426,082View SEC Filing Icon  
11/8/2019Sell5,369$234.37$1,258,332.5326,082View SEC Filing Icon  
8/9/2019Sell5,369$216.26$1,161,099.9426,082View SEC Filing Icon  
7/29/2019Sell21,000$211.92$4,450,320.0041,713View SEC Filing Icon  
7/10/2019Sell5,369$190.09$1,020,593.2126,082View SEC Filing Icon  
5/30/2019Sell3,000$169.60$508,800.0020,674View SEC Filing Icon  
5/17/2019Sell5,369$175.06$939,897.1426,043View SEC Filing Icon  
5/8/2019Sell300$178.54$53,562.0019,415View SEC Filing Icon  
3/13/2019Sell5,500$175.73$966,515.0024,482View SEC Filing Icon  
2/13/2019Sell5,500$177.75$977,625.0024,482View SEC Filing Icon  
12/12/2018Sell5,500$164.99$907,445.00View SEC Filing Icon  
10/10/2018Sell5,500$147.50$811,250.0025,490View SEC Filing Icon  
9/12/2018Sell5,500$144.16$792,880.0025,490View SEC Filing Icon  
8/31/2018Sell75$144.24$10,818.0019,990View SEC Filing Icon  
7/11/2018Sell5,500$145.57$800,635.00View SEC Filing Icon  
6/13/2018Sell5,500$150.00$825,000.0025,512View SEC Filing Icon  
4/4/2018Sell4,000$134.78$539,120.00View SEC Filing Icon  
3/29/2018Sell5,300$138.58$734,474.0024,908View SEC Filing Icon  
2/20/2018Sell5,300$134.70$713,910.0024,908View SEC Filing Icon  
2/12/2018Sell3,750$127.54$478,275.0019,608View SEC Filing Icon  
1/29/2018Sell5,300$127.24$674,372.0024,908View SEC Filing Icon  
12/28/2017Sell5,300$114.08$604,624.00View SEC Filing Icon  
12/28/2017Sell5,300$114.08$604,624.00View SEC Filing Icon  
11/29/2017Sell5,300$116.45$617,185.00View SEC Filing Icon  
10/30/2017Sell5,300$101.12$535,936.00View SEC Filing Icon  
9/29/2017Sell5,300$108.86$576,958.00View SEC Filing Icon  
8/29/2017Sell5,300$112.15$594,395.00View SEC Filing Icon  
8/4/2017Sell25,000$116.00$2,900,000.00View SEC Filing Icon  
7/28/2017Sell5,300$114.68$607,804.00View SEC Filing Icon  
6/29/2017Sell5,600$117.15$656,040.00View SEC Filing Icon  
5/8/2017Sell19,100$110.34$2,107,494.00View SEC Filing Icon  
5/4/2017Sell34,120$109.98$3,752,517.60View SEC Filing Icon  
4/5/2017Sell13,720$93.58$1,283,917.60View SEC Filing Icon  
3/6/2017Sell13,720$90.01$1,234,937.20View SEC Filing Icon  
1/12/2017Sell13,720$97.47$1,337,288.40View SEC Filing Icon  
11/2/2016Sell15,000$90.13$1,351,950.00View SEC Filing Icon  
9/2/2016Sell18,000$115.78$2,084,040.00View SEC Filing Icon  
5/31/2016Sell18,000$99.04$1,782,720.0062,796View SEC Filing Icon  
10/24/2014Sell30,000$114.25$3,427,500.00View SEC Filing Icon  
10/3/2014Sell25,000$105.00$2,625,000.00View SEC Filing Icon  
9/10/2014Sell25,000$100.00$2,500,000.00View SEC Filing Icon  
7/30/2014Sell23,270$92.00$2,140,840.00View SEC Filing Icon  
6/27/2014Sell25,000$87.00$2,175,000.00View SEC Filing Icon  
10/4/2012Sell11,530$110.14$1,269,914.20View SEC Filing Icon  
See Full Table

Donald E. Bobo, Jr Buying and Selling Activity at Edwards Lifesciences

This chart shows Donald E Bobo Jr's buying and selling at Edwards Lifesciences by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Edwards Lifesciences Company Overview

Edwards Lifesciences logo
Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.
Read More

Today's Range

Now: $88.53
Low: $86.20
High: $89.00

50 Day Range

MA: $87.56
Low: $84.23
High: $91.48

2 Week Range

Now: $88.53
Low: $60.57
High: $96.12


3,709,633 shs

Average Volume

2,165,861 shs

Market Capitalization

$53.35 billion

P/E Ratio


Dividend Yield